Emergent BioSolutions facility will process up to 250,000 litres of plasma annually.
Expanded strategic deal includes equipment and co-commercialization.
R&D project will expand Shenzhen Hepalink’s product line and diversification efforts.
Doubles revenues, records a profit of $800,000
NantPro will manufacture plasma-derived product for US market.
PrioClear prion capture resin is used in plasma product production.
ProMetic Life Sciences Inc. in Laval, Que. has signed a $10-million strategic manufacturing and licence deal with a drug manufacturer in Taiwan to co-develop and commercialize a pharma product that targets a rare medical condition (orphan).